| Ms Joanie Holm, CNP | |
|
400 22nd Ave, Brookings, SD 57006-2497 | |
| (605) 697-9500 | |
| (605) 697-6939 |
| Full Name | Ms Joanie Holm |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 400 22nd Ave, Brookings, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497844336 | NPI | - | NPPES |
| 6826543 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0200X | Nurse Practitioner - Pediatrics | 4629 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Joanie Holm, CNP 400 22nd Ave, Brookings, SD 57006-2497 Ph: (605) 697-9500 | Ms Joanie Holm, CNP 400 22nd Ave, Brookings, SD 57006-2497 Ph: (605) 697-9500 |
News Archive
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced miravirsen (SPC3649), the first microRNA-targeted drug to enter clinical trials, into Phase 2 studies to assess the safety and tolerability of the drug in treatment-naive patients infected with the Hepatitis C virus.
A Purdue University scientist's nanopolymer would make it easier and cheaper for drug developers to test the effectiveness of a widely used class of cancer inhibitors.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of high grade gliomas (HGG) in pediatric patients.
The University of North Dakota and Neomatrix, LLC, have signed an exclusive agreement to develop technology for the early detection of breast cancer using the company's HALO Breast Pap Test device.
Chelsea Therapeutics International, Ltd. has initiated enrollment in a multinational, 12-week, double-blind Phase II trial designed to compare the efficacy and tolerability of CH-4051 against methotrexate (MTX) in 250 patients with rheumatoid arthritis (RA) who are experiencing an inadequate response to MTX treatment.
› Verified 7 days ago
Dr. Jennifer Ann Redmond, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 22nd Ave, Brookings, SD 57006 Phone: 605-697-9555 | |
Dr. Rachel Lynde, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 922 22nd Ave S, Brookings, SD 57006 Phone: 605-697-1900 | |
Anne Marie Mcnally, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 922 22nd Ave S, Brookings, SD 57006 Phone: 605-697-1900 | |
Ashleigh Eilts, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 922 22nd Ave S, Brookings, SD 57006 Phone: 605-697-1900 | |
Sarah Sapp, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 22nd Ave, Brookings, SD 57006 Phone: 605-697-9500 Fax: 605-697-6939 | |
Lindsay Marie Rheault, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Wellness Ctr, Box 2818, Brookings, SD 57007 Phone: 605-688-4157 | |
Janae Louise Jacobsen, RN, MS, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1440 N Campus Dr, Wellness Center, Box 2818, Brookings, SD 57007 Phone: 605-688-4157 |